Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

80.90 +2.55 (+3.25%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about GeneDx Holdings Corp. - Class A Common Stock

< Previous 1 2 3 4 5 Next >
Verona Pharma, Rhythm Pharmaceuticals, AES And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Biotech Catalyst Alert: NKTR, CDTX & WGS Rallying With Big Gains
With major rallies and analyst backing, Nektar, Cidara, and GeneDx are drawing interest; will these biopharma firms maintain their growth trajectories? 
Via MarketBeat
Expert Outlook: GeneDx Holdings Through The Eyes Of 4 Analysts
Via Benzinga
Why GeneDX Stock Surged Higher This Week
Via The Motley Fool
Why GeneDx, An IBD 50 Stock, Has Skyrocketed 34% Over The Past Two Days
There's a new recommendation on genetic testing for children, and this stock is on the rise. 
Via Investor's Business Daily
Earnings Scheduled For April 30, 2025
Via Benzinga
Carnival Posts Better-Than-Expected Earnings, Joins Liminatus Pharma, Coinbase Global, Uber And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Analyst Expectations For GeneDx Holdings's Future
Via Benzinga
This National Vision Holdings Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday
Via Benzinga
Why Investors Were Avoiding GeneDx Holdings Stock This Week
Via The Motley Fool
Retail Buzz Swirls Around GeneDx As Shares Sink 43% Despite Earnings Beat
GeneDx shares plunged 43% despite strong Q1 results and raised guidance, drawing a surge in retail investor interest. The drop followed the company's first sequential test volume decline, which it... 
Via Stocktwits
Wednesday's session: top gainers and losers
Intrigued by the market activity one hour before the close of the markets on Wednesday? Uncover the key winners and losers of today's session in our insightful analysis. 
Via Chartmill
Top stock movements in today's session.
Looking for insights into the US markets in the middle of the day on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Wednesday's session: gap up and gap down stocks
The session on Wednesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session. 
Via Chartmill
Why GeneDx Holdings Stock Is Plunging Today
Via The Motley Fool
Crude Oil Falls Over 3%; Regulus Therapeutics Shares Spike Higher
Via Benzinga
These stocks that are showing activity before the opening bell on Wednesday.
Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top gainers and losers in today's pre-market session. 
Via Chartmill
S&P 500 Falls 2%; Caterpillar Reports Downbeat Q1 Results
Via Benzinga
Topics Stocks
IBD 50 Stock GeneDx Hammered Despite Earnings Beat-And-Raise
The company is an expert in using whole genome and exome sequencing to screen for genetic diseases. 
Via Investor's Business Daily
Topics Government
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Exploring high growth characteristics of GENEDX HOLDINGS CORP (NASDAQ:WGS).
UA fundamental and technical analysis of (NASDAQ:WGS): nlocking the high Growth Potential of GENEDX HOLDINGS CORP (NASDAQ:WGS). 
Via Chartmill
GeneDx Eyes Global Genomic Leadership With Fabric Genomics Buyout For Up To $51 Million
GeneDx (NASDAQ: WSG) to acquire Fabric Genomics, pioneer in AI-powered genomic interpretation, for up to $51 million. Expanding global reach and improving precision diagnostics. 
Via Benzinga
IBD 50's GeneDx Inks $84 Million AI-Tied Takeover Deal
GeneDx will pay up to $84 million to acquire Fabric Genomics for its AI-powered genomics interpretation platform. 
Via Investor's Business Daily
Topics Artificial Intelligence
Why GENEDX HOLDINGS CORP (NASDAQ:WGS) could fit Mark Minervini’s high-growth criteria
A fundamental and technical analysis of (NASDAQ:WGS): Should you consider GENEDX HOLDINGS CORP (NASDAQ:WGS) for high growth investing? 
Via Chartmill
Unlocking the high Growth Potential of GENEDX HOLDINGS CORP (NASDAQ:WGS).
Exploring high growth characteristics of GENEDX HOLDINGS CORP (NASDAQ:WGS). A fundamental and technical analysis of (NASDAQ:WGS). 
Via Chartmill
Does GENEDX HOLDINGS CORP (NASDAQ:WGS) align with Mark Minervini’s trading strategy?
A fundamental and technical analysis of (NASDAQ:WGS): Why the high growth investor may take a look at GENEDX HOLDINGS CORP (NASDAQ:WGS). 
Via Chartmill
SPY Trying To Find A Floor At The 200 SMA; One New Swing
In this video lesson I review the day-one of a new rally attempt in the overall market, discuss my new swing trade in a cyber-security leader, and review my tier-one long-term portfolio purchases in my... 
Via Talk Markets
Topics Stocks / Equities
Powerful UnR Session As All Four Market Indices Lockstep Rally Into The Close; Bear Trap Set?
In this video lesson, I review the overall market, the recent bearish sentiment, and one new swing trade idea for Monday's session. 
Via Talk Markets
Topics Stocks / Equities
Top Biotech GeneDx Catapults 42% After Obliterating Earnings Forecasts
GeneDx stock catapulted more than 40% on Tuesday after the top-notch biotech smashed fourth-quarter expectations. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS